Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Barclays
BCS
$94.6B
| $756K | ﹤0.01% |
95,891
-4,575
| -5% | -$33K |
|
2927
Park Aerospace
PKE
$838M
| $755K | ﹤0.01% |
51,368
| – | – |
|
2928
Bridgewater Bancshares
BWB
$613M
| $748K | ﹤0.01% |
55,290
| – | – |
|
|
TERN
2929
DELISTED
Terns Pharmaceuticals
TERN
| $744K | ﹤0.01% |
114,609
| – | – |
|
2930
John Marshall Bancorp
JMSB
$330M
| $743K | ﹤0.01% |
32,930
| – | – |
|
|
PBPB
2931
DELISTED
Potbelly
PBPB
| $742K | ﹤0.01% |
71,211
-146
| -0.2% | -$1.33K |
|
2932
Gevo
GEVO
$391M
| $736K | ﹤0.01% |
634,112
-2,211
| -0.3% | -$2.52K |
|
2933
BayCom
BCML
$340M
| $734K | ﹤0.01% |
31,104
-645
| -2% | -$13.5K |
|
2934
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $733K | ﹤0.01% |
+24,931
| New | +$698K |
|
2935
Accuray
ARAY
$33.6M
| $733K | ﹤0.01% |
258,917
+9,052
| +4% | +$24.7K |
|
2936
First Bancorp
FNLC
$402M
| $733K | ﹤0.01% |
25,964
| – | – |
|
2937
Kodiak Sciences
KOD
$2.71B
| $733K | ﹤0.01% |
240,996
+3,080
| +1% | +$6.85K |
|
2938
Alcon
ALC
$35.6B
| $729K | ﹤0.01% |
9,333
-1,726
| -16% | -$127K |
|
2939
Red River Bancshares
RRBI
$676M
| $729K | ﹤0.01% |
12,991
| – | – |
|
2940
Willdan Group
WLDN
$1.29B
| $729K | ﹤0.01% |
33,889
| – | – |
|
2941
Third Coast Bancshares
TCBX
$758M
| $725K | ﹤0.01% |
36,482
| – | – |
|
2942
EverQuote
EVER
$858M
| $724K | ﹤0.01% |
59,126
+2,378
| +4% | +$21.6K |
|
2943
Fidelity D&D Bancorp
FDBC
$318M
| $722K | ﹤0.01% |
12,446
+7
| +0.1% | +$354 |
|
|
KEEL
2944
Keel Infrastructure Corp
KEEL
$2.22B
| $721K | ﹤0.01% |
247,843
-3,786
| -2% | -$6.08K |
|
|
HUT
2945
Hut 8
HUT
$11.4B
| $718K | ﹤0.01% |
53,801
+10,848
| +25% | +$116K |
|
2946
Primis Financial Corp
FRST
$412M
| $717K | ﹤0.01% |
56,616
| – | – |
|
2947
Voyager Therapeutics
VYGR
$197M
| $715K | ﹤0.01% |
84,737
-3,436
| -4% | -$24.9K |
|
|
MRSN
2948
DELISTED
Mersana Therapeutics
MRSN
| $715K | ﹤0.01% |
12,323
+547
| +5% | +$22K |
|
2949
Rayonier Advanced Materials
RYAM
$575M
| $703K | ﹤0.01% |
173,494
-105,791
| -38% | -$348K |
|
|
DFTX
2950
Definium Therapeutics
DFTX
$5.75B
| $702K | ﹤0.01% |
191,874
+3,338
| +2% | +$10.1K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.